" class="no-js "lang="en-US"> Caroline Germa - Medtech Alert
Friday, October 03, 2025
Caroline Germa

Caroline Germa

About Caroline Germa

Dr. Caroline Germa is an accomplished medical oncologist and medicine development leader with over 20 years of pharmaceutical experience, across the spectrum of drug development, from early clinical trials to late phase and registration. She used to work for AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer Eli Lilly France and Sanofi/Aventis. MD and Medical Oncologist Degree, as well as Breast Disease and Immunology Master Degrees from Paris and Lille University, France.

Related Story

Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer

August 8 2022

Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in […]